A kind of traditional Chinese medicine hemostatic powder

Abstract

The invention discloses a traditional Chinese medicine hemostatic powder, which is prepared by grinding and mixing the following ingredients in the weight ratio: 10-20 safflower, 10-30 Codonopsis 10-30, 10-30 yam, 10 Ligustrum lucidum ~30, Poria 10~30, Angelica 10~30, Eucommia 10~30, Peach Kernel 10~30, Alisma 10~20, Chuanxiong 20~50, Atractylodes macrocephala 20~50, Radix Paeoniae Alba 10~30, Paeoniae Alba 10~30 . The hemostatic powder of the present invention is a traditional Chinese medicine formulated according to the performance and efficacy of the medicine combined with the characteristics of traumatic hemorrhage and can be used internally or externally. The hemostatic powder of the invention is a pure traditional Chinese medicine without side effects; it is all common medicinal materials, has a wide range of medicine sources, is cheap, greatly reduces the cost of hemostasis and treatment; the preparation method is simple, and the production cost is low. The curative effect is extraordinary, and the effect is like a god. The pain disappears quickly after taking the medicine, and the wound is not inflamed or suppurated. Direct application of medicine to wounds without dressing with gauze or cotton wool.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for hemostasis, in particular to a traditional Chinese medicine hemostatic powder which can be applied externally and taken internally. Background technique [0002] Blood is an important substance in the human body. In any hemorrhage, if the bleeding is not stopped effectively in time, the blood will be wasted, resulting in weakness of the body and even life-threatening. Therefore, the application of hemostatic drugs is of great significance. Existing hemostatic drugs are mainly western medicines, which have a certain therapeutic effect, often have relatively large side effects, and are more expensive, such as antifibrinolytic western medicines, which inhibit the activator of plasminogen so that plasminogen cannot Activated to inhibit the dissolution of fibrin. Representative drugs include aminocaproic acid, aminomethylbenzoic acid, and tranexamic acid. These drugs have better effects...

AI Technical Summary

Problems solved by technology

Existing hemostatic drugs are mainly western medicines, which have a certain therapeutic effect, often have relatively large side effects, and are more expensive, such as antifibrinolytic western medicines, which inhibit the activator of plasminogen so that plasminogen cannot Activated to inhibit the dissolution of fibrin. Representative drugs include aminocaproic acid, aminomethylbenzoic acid, and tranexamic acid. These drugs have better effects on general chronic bleeding, but are less effective on cancer bleeding and traumatic bleeding. Common The adverse reactions include headache, dizziness, nausea, vomiting and diarrhea, etc. It is contraindicated for elderly patients and those with a history of thrombosis and embolic vascular disease

Existing types are of a great variety, each of which has its own advantages, but also has its own limitations: some have a single symptom and lack versatility; some have a slow hemostatic speed and a long course of treatment; Either internally or externally